Literature DB >> 6743468

The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris.

B Silke, S P Verma, G I Nelson, R C Ahuja, M Hussain, S H Taylor.   

Abstract

The differences between slow calcium blocking agents with respect to effects on heart rate, myocardial contractility and atrioventricular conducting time are well described; the relevance of such differences to the treatment of patients with impaired left ventricular function due to coronary heart disease is uncertain. The haemodynamic effects of equivalent hypotensive doses of nifedipine and verapamil were therefore compared in 20 patients with severe angina pectoris associated with angiographically documented coronary artery disease. The plasma concentrations of nifedipine (mean 57 +/- 19; range 27-77 ng/ml) and verapamil (mean 147 +/- 14; range 117-260 ng/ml) at the time of the haemodynamic measurements were of an order usually associated with substantial pharmacodynamic activity. Sitting at rest nifedipine resulted in reduction in systemic arterial pressure (P less than 0.05) and vascular resistance (P less than 0.01); both the heart rate (P less than 0.01) and cardiac output (P less than 0.05) increased without any significant change in the left heart filling pressure. In contrast, verapamil, which similarly reduced systemic blood pressure (P less than 0.05) and vascular resistance (P less than 0.01), increased cardiac output (P less than 0.05) and left heart filling pressure (P less than 0.05) without any change in heart rate. During upright bicycle exercise both drugs attenuated the angina induced in all subjects during the control exercise period. Despite reductions in systemic blood pressure and vascular resistance the cardiac output was unaltered on either drug at the same workload as in the control assessment. The reduction in exercise blood pressure following nifedipine induced a reflex tachycardia; this was not present, despite the similar hypotensive action, after verapamil.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743468      PMCID: PMC1463428          DOI: 10.1111/j.1365-2125.1984.tb02411.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

Review 1.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Effect of propranolol on left ventricular function, segmental wall motion, and diastolic pressure-volume relation in man.

Authors:  J Coltart; E L Alderman; S C Robison; D C Harrison
Journal:  Br Heart J       Date:  1975-04

3.  Comparison of verapamil and nifedipine in the treatment of variant angina pectoris: preliminary observations in 10 patients.

Authors:  S M Johnson; D R Mauritson; J T Willerson; L D Hillis
Journal:  Am J Cardiol       Date:  1981-06       Impact factor: 2.778

4.  Identification of nifedipine metabolites and their determination by gas chromatography.

Authors:  S Kondo; A Kuchiki; K Yamamoto; K Akimoto; K Takahashi; N Awata; I Sugimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-01       Impact factor: 1.645

5.  Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease.

Authors:  A Reale; A Nigri; P A Gioffrè; M Motolese
Journal:  Eur J Cardiol       Date:  1979-02

6.  Fluorometric assay of verapamil in biological fluids and tissues.

Authors:  R G McAllister; S M Howell
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

7.  Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging.

Authors:  G J Dehmer; M Falkoff; S E Lewis; L D Hillis; R W Parkey; J T Willerson
Journal:  Br Heart J       Date:  1981-06

8.  Effects of verapamil on myocardial performance in coronary disease.

Authors:  J Ferlinz; J L Easthope; W S Aronow
Journal:  Circulation       Date:  1979-02       Impact factor: 29.690

9.  Effects of intravenous verapamil on hemodynamics in patients with heart disease.

Authors:  B N Singh; A H Roche
Journal:  Am Heart J       Date:  1977-11       Impact factor: 4.749

10.  Effects of nifedipine on resistance vessels, arteries and veins in man.

Authors:  B F Robinson; R J Dobbs; C R Kelsey
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

View more
  7 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 3.  Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.

Authors:  R N Brogden; P Benfield
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

4.  Effects of nicardipine on cardiac volume at rest and during exercise-induced angina.

Authors:  B Silke; S P Verma; M A Frais; M Hafizullah; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 5.  Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.

Authors:  C H Kleinbloesem; P van Brummelen; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

6.  Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.

Authors:  B Silke; D J Graham; S P Verma; G Reynolds; M A Frais; J R Finlayson; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 7.  The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.

Authors:  A L Soward; G L Vanhaleweyk; P W Serruys
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.